Patents Assigned to R1 B3 Holding B.V.
  • Patent number: 9803212
    Abstract: The present invention pertains to a method of expressing a protein of interest, preferably a heterologous protein, in preferably a plant. In a preferred embodiment said plant is a doubled haploid homozygous transgenic Nicotiana tabacum plant silenced for Ntp303. Furthermore, the invention relates to said plant with or without nucleic acid constructs according to the invention. Propagation, harvest and tissue material of said transgenic Nicotiana tabacum plant is also a part of the invention.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: October 31, 2017
    Assignee: R1 B3 Holding B.V.
    Inventors: Marinus Maria Antonius Van Herpen, Jozef Maurinus Raymond Hulzink, Anton Felix Croes
  • Publication number: 20140127747
    Abstract: The present invention pertains to a method of expressing a protein of interest, preferably a heterologous protein, in preferably a plant. In a preferred embodiment said plant is a doubled haploid homozygous transgenic Nicotiana tabacum plant silenced for Ntp303. Furthermore, the invention relates to said plant with or without nucleic acid constructs according to the invention. Propagation, harvest and tissue material of said transgenic Nicotiana tabacum plant is also a part of the invention.
    Type: Application
    Filed: November 5, 2013
    Publication date: May 8, 2014
    Applicant: R1 B3 Holding B.V.
    Inventors: Marinus Maria Antonius Van Herpen, Jozef Maurinus Raymond Hulzink, Anton Felix Croes
  • Publication number: 20130239236
    Abstract: The present invention describes mRNA usage improving and/or translation-enhancing nucleic acid sequences, nucleic acid constructs comprising such sequences, and host cells comprising such nucleic acid constructs. The invention further pertains to a method for expressing a protein of interest in a cell or organism using such nucleic acid sequences, as well as their uses for increasing integration of such nucleic acid construct into a genome, for enhancing mRNA usage and/or translation of a recombinantly expressed polypeptide, and for increasing the number of transformants upon transformation of a cell with such nucleic acid construct.
    Type: Application
    Filed: September 30, 2011
    Publication date: September 12, 2013
    Applicant: R1 B3 Holdings B.V.
    Inventors: Raymond Michael Dimphena Verhaert, Pieter Victor Schut, Sharief Barends, Maurice Wilhelmus van der Heijden